Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4583256
Max Phase: Preclinical
Molecular Formula: C33H45N5O5S
Molecular Weight: 623.82
Molecule Type: Unknown
Associated Items:
ID: ALA4583256
Max Phase: Preclinical
Molecular Formula: C33H45N5O5S
Molecular Weight: 623.82
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CNC3CC3)c3cc[nH]c3n2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C33H45N5O5S/c1-6-31(4)15-23(32(5)18(2)9-12-33(19(3)27(31)42)13-10-22(39)26(32)33)43-25(41)17-44-30-37-28-21(11-14-34-28)29(38-30)36-24(40)16-35-20-7-8-20/h6,11,14,18-20,23,26-27,35,42H,1,7-10,12-13,15-17H2,2-5H3,(H2,34,36,37,38,40)/t18-,19+,23-,26+,27+,31-,32+,33+/m1/s1
Standard InChI Key: NLOPQPNGSVZYAL-PYGIMHBNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 623.82 | Molecular Weight (Monoisotopic): 623.3141 | AlogP: 4.65 | #Rotatable Bonds: 9 |
Polar Surface Area: 146.30 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.47 | CX Basic pKa: 8.12 | CX LogP: 4.43 | CX LogD: 3.63 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.14 | Np Likeness Score: 0.67 |
1. Deng Y, Wang XZ, Huang SH, Li CH.. (2019) Antibacterial activity evaluation of synthetic novel pleuromutilin derivatives in vitro and in experimental infection mice., 162 [PMID:30445267] [10.1016/j.ejmech.2018.11.006] |
Source(1):